Member

Amsel Medical Corporation


Amsel Medical Corporation specializes in the development and commercialization of minimally invasive medical devices for trauma, vascular, and general surgical applications. Its core innovation centers on unique temporary and permanent vessel clamping technologies delivered via needle guidance. For trauma, the company is developing a field-deployable precision hemorrhage control solution for combat and civilian non-compressible junctional hemorrhage injuries . The solution can adjust the degree of vessel occlusion and distal perfusion, minimizing the potential consequences of prolonged limb ischemia and "reperfusion injury", and most importantly extends the "golden hour" for safe evacuation. Saving Limbs...Saving Lives.

Industries

N/A

Nr. of Employees

small (1-50)

Amsel Medical Corporation

Amsel Medical Corporation is currently seeking investment

Amsel Medical Corporation is seeking a series-b investment in the range of 1m-5m

All Investment-seeking Members

Products

Minimally invasive vascular and ductal occlusion device

Device for secure closure of blood vessels, ducts, arteries, and veins during surgical and interventional procedures, delivered through an 18 G needle with a mechanical anchoring feature. Indicated for use in tubular structures or vessels where metal ligation clips are required, sized 2.0mm to 7.0mm diameter.

Expertise Areas

  • Vascular surgery devices
  • Surgical hemostasis and vessel closure
  • Trauma and military medicine solutions
  • Preclinical device evaluation
  • Show More (1)

Key Technologies

  • Minimally invasive vessel occlusion
  • Ultrasound-guided device delivery
  • Mechanical vascular clip technology

Key People

James A. Heinz, MSL

Chief Executive Officer

LinkedIn

News & Updates

Journal of Vascular Surgery article detailing a study confirming effective ultrasound-guided, percutaneous occlusion in the porcine model.

Published in Surgical Endoscopy, this preclinical study compared device performance during laparoscopic surgery with conventional methods.

Journal of Surgical Research article detailing comparative evaluation of the mechanical occlusion device and traditional non-transfixing clips in animal models.

Received Department of Defense U.S. Air Force AFWERX Phase 2 SBIR grant to develop trauma-oriented temporary clamping device for reducing military front-line deaths due to non-compressible hemorrhage.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.